Use of Immune Checkpoint Inhibitors in End Stage Kidney Disease Patients, Single Center Experience and Review of the Literature
Author:
Publisher
American Society of Nephrology (ASN)
Subject
General Medicine
Reference24 articles.
1. Clinical pharmacokinetics and pharmacodynamics of immune checkpoint inhibitors;Centanni;Clin Pharmacokinet,2019
2. Safety and efficacy of immune checkpoint inhibitors for end-stage renal disease patients undergoing dialysis: A retrospective case series and literature review;Cheun;Invest New Drugs,2019
3. Immunotherapy in dialysis-dependent cancer patients: Our experience in patients with metastatic renal cell carcinoma and a review of the literature;Vitale;Clin Genitourin Cancer,2019
4. Lapman S , Whittier W , Parikh R , Khanin Y , Bijol V , Wanchoo R , Jhaveri KD : Immune checkpoint inhibitor associated Renal AA amyloidosis, a case series and review of the literature [published online ahead of print March 17, 2020]. J Onco-Nephrol doi:10.1177/2399369320907598
5. Ipilimumab was safe and effective in two patients with metastatic melanoma and end-stage renal disease;Cavalcante;Cancer Manag Res,2015
Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Sex differences in cancer outcomes across the range of eGFR;Nephrology Dialysis Transplantation;2024-03-09
2. Metastatic Melanoma Treatment in Special Populations;The Cancer Journal;2024-03
3. Case report: Successful treatment of a patient undergoing haemodialysis with multifocal hepatocellular carcinoma using atezolizumab and bevacizumab;Frontiers in Oncology;2024-01-04
4. Nephrotoxicity of combination drug therapy in metastatic renal cancer;Cancer Urology;2023-11-16
5. Maintenance avelumab therapy for urothelial carcinoma in a hemodialysis patient: a case report;International Cancer Conference Journal;2023-11-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3